The Evaluation of Iron Deficiency and Iron Overload.
Gattermann N, Muckenthaler MU, Kulozik AE, Metzgeroth G, Hastka J.
Dtsch Arztebl Int. 2021 Dec 10;118(49):847-856. doi: 10.3238/arztebl.m2021.0290.
Anemia and iron overload as prognostic markers of outcomes in beta-thalassemia.
Musallam KM, Sheth S, Cappellini MD, Forni GL, Maggio A, Taher AT.
Expert Rev Hematol. 2024 Sep;17(9):631-642. doi: 10.1080/17474086.2024.2383420. Epub 2024 Jul 26.
Hepcidin and Iron in Health and Disease.
Nemeth E, Ganz T.
Annu Rev Med. 2023 Jan 27;74:261-277. doi: 10.1146/annurev-med-043021-032816. Epub 2022 Jul 29.
Ineffective Erythropoiesis: Anemia and Iron Overload.
Gupta R, Musallam KM, Taher AT, Rivella S.
Hematol Oncol Clin North Am. 2018 Apr;32(2):213-221. doi: 10.1016/j.hoc.2017.11.009. Epub 2017 Dec 29.
Sickle cell disease.
Ware RE, de Montalembert M, Tshilolo L, Abboud MR.
Lancet. 2017 Jul 15;390(10091):311-323. doi: 10.1016/S0140-6736(17)30193-9. Epub 2017 Feb 1.
Iron metabolism and iron disorders revisited in the hepcidin era.
Camaschella C, Nai A, Silvestri L.
Haematologica. 2020 Jan 31;105(2):260-272. doi: 10.3324/haematol.2019.232124. Print 2020.
Congenital dyserythropoietic anemias.
Iolascon A, Andolfo I, Russo R.
Blood. 2020 Sep 10;136(11):1274-1283. doi: 10.1182/blood.2019000948.
Iron overload and iron chelating agent exposure in anemia-associated outer retinal degeneration: a case report and review of the literature.
Belmouhand M, Eckmann-Hansen C, Ilginis T, Leinøe EB, Mortensen BK, Larsen M.
BMC Ophthalmol. 2021 Jul 13;21(1):277. doi: 10.1186/s12886-021-02030-1.
Current understanding of iron homeostasis.
Anderson GJ, Frazer DM.
Am J Clin Nutr. 2017 Dec;106(Suppl 6):1559S-1566S. doi: 10.3945/ajcn.117.155804. Epub 2017 Oct 25.
Hepcidin and iron homeostasis.
Ganz T, Nemeth E.
Biochim Biophys Acta. 2012 Sep;1823(9):1434-43. doi: 10.1016/j.bbamcr.2012.01.014. Epub 2012 Jan 26.
